Endometrial Ablation Market by Device Type (Hysteroscopy Devices, Thermal Balloon Ablators, Radiofrequency Endometrial Ablation Devices, Hydrothermal Ablators, Electrical Ablators, and Others), End User (Ambulatory Surgical Centers, Hospitals, and Clinics) and Geography: Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00027038 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed the US$ 3.98 billion mark in 2022 and is expected to hit US$ 5.82 billion by 2030, recording a CAGR of 4.9% during the forecast period. 

The endometrial ablation market has grown significantly due to the increasing preference for minimally invasive procedures.

Minimally invasive technologies have been associated with less pain, smaller incisions, shorter hospital stays, quick recovery, and increased accuracy, which is leading to a more adoption for these techniques globally. Furthermore, patients undertaking minimally invasive surgeries do not require large doses of painkillers because of manageable discomfort and bearable pain. Minimally invasive procedures help heal faster than conventional surgeries, thereby allowing patients to get back to their normal lives as quickly. These advantages of the minimally invasive surgeries enabled with RF ablation technique fuel the global radiofrequency ablation devices market growth.  In 2021, radiofrequency endometrial ablation devices held the maximum share in the global market, mainly due to the emerging applications of radiofrequency ablation technology and the rising preference for minimally invasive surgical procedures.

Within the report, the market is segmented into device type, end user and geography. By device type, the market is segmented into hysteroscopy devices, thermal balloon ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, electrical ablators, and others. The end user segments the market into ambulatory surgical centers, hospitals, and clinics. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Radiofrequency endometrial ablation devices hold the largest market share by device type

Radiofrequency ablation is a minimally invasive technique that destroys cancer cells and other dysfunctional tissues. In recent years, it has been used to treat various medical conditions. Radio ablation is widely used in gynecology to treat uterine fibroids. Thus, the broadening range of applications of radiofrequency ablation technology in surgical oncology is expected to grow significantly. Therefore, the wide application of radiofrequency ablation and an increasing number of cancer patients across the globe will drive the growth of the global endometrial ablation market.

Increasing incidences of various gynecological disorders is one of the major factors accelerating market growth.

Endometrial ablation is a technique that surgically removes the lining of the uterus. It reduces menstrual flow in some women. The major factor attributing to the market's growth is the increase in the prevalence of gynecological disorders like cervical cancer, menorrhagia, abnormal vaginal bleeding, and polycystic ovarian disease (PCOD) in women.

Cervical cancer is associated with abnormal changes or growth of cervical cells. According to a recent study published in Women's Health journal, in India, around 0.2 million cervical cancer cases are diagnosed yearly. Moreover, according to the World Health Organization (WHO), in 2018, about 0.3 million women died of cancer worldwide. Such high prevalence and mortality associated with cervical cancer are expected to offer a favorable environment. Rising cases are expected to raise the adoption of endometrial ablation in years.

Recent strategic developments in the endometrial ablation market

The endometrial ablation market has undergone several significant developments, and a few of these have been mentioned below:

  • In December 2017, BD acquired C. R. Bard, Inc. The acquisition created a new healthcare industry leader in the global market. With its robust product offerings and unique pipeline, Bard's has increased the scope for opportunities in the fast-growing medical devices business in the international markets.
  • In February 2017, Hologic Inc. launched a next-generation NovaSure ADVANCED global endometrial ablation (GEA) system in the US market. The FDA approved the system's sale in the US. This product approval strengthened the company's business in the US and benefited associated business operations.

Several players drive the endometrial ablation market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Boston Scientific Corporation; Medtronic; Hologic, Inc.; Cooper Surgical; Johnson & Johnson; Olympus Corporation; Richard Wolf GmbH; Minerva Surgical, Inc.; AngioDynamics are among the prominent players operating in the market.

Target audience for the report:

  • Raw material providers
  • Market-related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policymakers
  • Venture capitalists, private equity firms, and start-up companies
  • Distributors and sales firms
  • End users of medical devices
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Device Type:
    • Hysteroscopy Devices
    • Thermal Balloon Ablators
    • Radiofrequency Endometrial Ablation Devices
    • Hydrothermal Ablators
    • Electrical Ablators
    • Others
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Clinics
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Boston Scientific Corporation
    • Medtronic
    • Hologic, Inc.
    • Cooper Surgical
    • Johnson & Johnson
    • Olympus Corporation
    • Richard Wolf GmbH
    • Minerva Surgical, Inc.
    • AngioDynamics

The List of Companies
- Boston Scientific Corporation
- Medtronic
- Hologic, Inc.
- Cooper Surgical
- Johnson & Johnson
- Olympus Corporation
- Richard Wolf GmbH
- Minerva Surgical, Inc.
- AngioDynamics

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500